The use of digoxin was associated with a slightly improved survival but no difference in rate of rehospitalization in a new study based on a nationwide propensity-matched cohort of Danish patients with heart failure and atrial fibrillation (AF). Lead author Dr Christian Madelaire (Gentofte University Hospital, Copenhagen, Denmark) presented these findings in an oral session […]
According to a study, a common clinical risk score (CHA2DS2-VASc) predicted ischemic stroke, thromboembolism, and death among patients with heart failure with or without atrial fibrillation, but only modestly.
Non-valvular atrial fibrillation (NVAF) is the most common arrhythmia. Patients with NVAF are at increased risk of stroke, therefore we evaluated the efficacy and safety of different approaches to prevent this major complication.